Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis

Transplant Proc. 1995 Feb;27(1):1213-4.

Authors

R W McGory¹, M B Ishitani, W M Oliveira, W C Stevenson, R C Dickson, S H Caldwell, T L Pruett

Affiliation

¹ Department of Surgery, University of Virginia Health Sciences, Charlottesville 22908.

PMID: 7878854

No abstract available

MeSH terms

Adult
Antiviral Agents / therapeutic use*
Arabinofuranosyluracil / analogs & derivatives*
Arabinofuranosyluracil / therapeutic use
Arabinofuranosyluracil / toxicity
DNA, Viral / blood
Female
Hepatitis B / complications
Hepatitis B / therapy*
Hepatitis B Core Antigens / blood
Hepatitis B Surface Antigens / blood
Hepatitis B e Antigens / blood
Hepatitis B virus / isolation & purification*
Humans
Immunoglobulins, Intravenous / pharmacokinetics*
Immunoglobulins, Intravenous / therapeutic use
Liver Cirrhosis / surgery*
Liver Transplantation* / pathology
Male

Substances

Antiviral Agents
DNA, Viral
Hepatitis B Core Antigens
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Immunoglobulins, Intravenous
Arabinofuranosyluracil
fialuridine